Acrivon Therapeutics (ACRV) Total Liabilities (2021 - 2026)
Acrivon Therapeutics (ACRV) posted Total Liabilities of $12.43 million for Q2 2026, down 20.1% from $15.55 million a year earlier but up 0.9% from the prior quarter.
Acrivon Therapeutics (ACRV) Total Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, Acrivon Therapeutics' Total Liabilities came in at $17.2 million, down 13.1% from FY2024.
- Annual Total Liabilities shows a four-year compound annual growth rate of -39.7% (FY2021 to FY2025).
- In prior years, Acrivon Therapeutics' Total Liabilities was $19.8 million in FY2024 (+16.0%), $17.07 million in FY2023 (+58.8%), $10.75 million in FY2022 (-91.8%) and $130.4 million in FY2021.
- Quarterly Total Liabilities has run from a low of $9.73 million in Q1 2023 to a high of $133.33 million in Q3 2022 over five years.
- On a year-over-year basis, Total Liabilities has declined in each of the last four quarters, with growth averaging 3.2% over the last eight quarters.
- The strongest year-over-year quarter for Total Liabilities in the past five years was Q4 2023, with growth of 58.8%; the weakest was Q4 2022, with a decline of 91.8%.
- According to Business Quant data, Total Liabilities for the three prior quarters was $12.32 million (Q1 2026), $17.2 million (Q4 2025) and $16.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 107.80 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 115.90 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 152.26 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 87.83 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 68.11 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 81.70 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 38.37 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 115.70 Bn |
| 10 | Acrivon Therapeutics | 67.27 Mn | -368.26 Mn | - | 12.43 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.43 Mn |
| Mar 31, 2026 | 12.32 Mn |
| Dec 31, 2025 | 17.20 Mn |
| Sep 30, 2025 | 16.70 Mn |
| Jun 30, 2025 | 15.55 Mn |
| Mar 31, 2025 | 15.96 Mn |
| Dec 31, 2024 | 19.80 Mn |
| Sep 30, 2024 | 17.79 Mn |
| Jun 30, 2024 | 14.53 Mn |
| Mar 31, 2024 | 12.54 Mn |
| Dec 31, 2023 | 17.07 Mn |
| Sep 30, 2023 | 12.94 Mn |
| Jun 30, 2023 | 10.87 Mn |
| Mar 31, 2023 | 9.73 Mn |
| Dec 31, 2022 | 10.75 Mn |
| Sep 30, 2022 | 133.33 Mn |
| Dec 31, 2021 | 130.40 Mn |
Acrivon Therapeutics Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=ACRV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();